Portage invests in iOx Therapeutics, an United Kingdom-based cancer immunotherapy companyPR Newswire (press release)TORONTO, March 8, 2018 /PRNewswire/ – Portage Biotech Inc. ("Portage" or "the Company") (Canadian Securities Exchang… Continue reading
Endpoints News |
Prevail Gets $75M For Parkinson’s Gene Therapy, Bolstering NY Biotech
Xconomy A potential gene therapy for Parkinson’s disease has just gotten a big boost thanks to one of the larger Series A investment rounds in years for a New York biotech. The funding, for Prevail Therapeutics, provides another jolt for the city’s life … Prevail grabs $75MA round in the hunt for new gene therapies to stop the destruction caused by Parkinson’sEndpoints News Prevail Therapeutics Announces $75 Million Series A Financing to Advance Gene Therapies for Patients with …Business Wire (press release) |